To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Podcast: Listen
Hesham Gayar, M.D., a board certified radiation oncologist, is Medical Director for the McLaren Proton Therapy Center, part of the Karmanos Cancer Network. He also serves as Vice President for the Particle Therapy Co-Operative Group (PTCOG) -North American Chapter and as a board member and Steering Committee member for PTCOG worldwide. His involvement in proton therapy also includes membership on the Executive Committee of the Proton Collaborative Group Medical Societies and as a member of the World Forum on Particle Therapy Strategic Planning for 2030. He holds numerous leadership positions at McLaren, including serving as chairman of the Department of Radiation Oncology at McLaren Flint, Associate Medical Director of the Karmanos Cancer Institutes at McLaren Flint and Lapeer, Chairman of the Research Advisory Board at McLaren Health Care, and Chairman of the Karmanos Cancer Institute Clinical Leadership Council.
Dr. Gayar earned his medical degree from the Alexandria School of Science in Egypt and completed a residency at St. Vincent’s Hospital in New York and a fellowship at Ohio State University. He also completed training in proton therapy at the Paul Scherrer Institute. He is past president of the Board of Directors of the Genesee County Medical Society, a RTOG Principal Investigator with the Michigan State Medical Society, an American College of Surgeons Liaison Physician and a member of the Scientific Advisory Board for the Cancer Terminator Foundation.
Hersham Gayar, M.D., discusses the advantage of McLaren's Proton Therapy Center, which is part of the Karmanos Cancer Network.